BioAdvance News

Immunome Reports Third Quarter 2021 Financial Results

By WebmasterNovember 15, 2021November 1st, 2024No Comments

Immunome Reports Third Quarter 2021 Financial Results

– IMM-BCP-01 Progressing Towards IND Filing –

Previous PostImmunome Announces Submission of an Investigational New Drug (IND) Application for IMM-BCP-01 for the Treatment of COVID-19
Next PostRenovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update